Background {#s1}
==========

The WNT/β-catenin pathway is implicated in many forms of human disease including cancer β-catenin, a key factor in the Wnt signaling involved in the tumorigenesis of colorectal cancer. The high expression and dysregulation of β-catenin, which is related to the Wnt signaling pathway, is involved in various human diseases, especially colon cancers \[[@R01],[@R02]\].β-Catenin, a messenger molecule relevant to growth and survival is degraded through the ubiquitin-proteasome pathway. Recently, evidence has also indicated that the dysregulation of Wnt/β-catenin signaling has been implicated in hematological malignancies, including MM \[[@R03]\].The related factors include increased expression of Wnt transcriptional cofactors and associated micro RNAs and disturbed epigenetics and posttranslational modification processes \[[@R04],[@R05]\]. WNT/β-catenin signaling is also an evolutionarily conserved pathway that plays a crucial role in cellular proliferation, differentiation, and migration in multiple organ systems \[[@R06]\]. WNT activation can induce two different pathways, the β-catenin-dependent canonical pathway and the β-catenin-independent non-canonical pathway. In the absence of WNT ligands, β-catenin is recruited and degraded by the destruction complex. Binding of WNT to its receptors disrupts the destruction complex, thereby inducing cytoplasmic accumulation of β-catenin and subsequent translocation to the nucleus \[[@R07]\]. Over 90% of colorectal cancer is carried out by somatic mutations in Wnt signalling constituent genes like adenomatous polyposis coli (APC) tumor suppressor gene and β-catenin genes, resulting in constitutive activation of Wnt signalling \[[@R08]\]. This in turn guides to the generation of colon cancer, which are intrinsically resistant to conventional chemotherapy. Genetic changes in the adenomatous polyposis coli (APC) gene have been recognized in familial adenomatous polyposis coli and determined in a group of sporadic colorectal cancers \[[@R09]\]. Hence, therapeutics that can block Wnt signaling are possible to get rid of cancer cells and treat the disease. Therefore, discovery of new genes involved or deregulated in CRCs may give vital insights for development of new sustainable therapeutic interventions. In order to design new inhibitor that deregulate the β-catenin activity ten alkaloid natural compounds were selected for the present study ([Table 1](#T1){ref-type="table"}).

Materials and Methods: {#s2}
======================

Protein preparation: {#s2a}
--------------------

High--resolution structure of Beta-catenin ([Figure 1](#F1){ref-type="fig"}) was downloaded from PDB (PDB Id: 1JDH) \[[@R10]\]. In the first of protein preparations removing other chains expect A chain and then water molecules which was observed crystallographic ally was removed. Finally prepared protein was uploaded to the Patch dock server for docking studies.

Ligand preparation: {#s2b}
-------------------

In our present study, selected ten natural alkaloid compounds were retrieved from pubchem database in SDF format and it was converted as PDB file format using Online Smile Translator. Energy minimizations of ligands were performed using by ChemBio 3D Ultra 12.0, based on the reported method. Energy minimized structures of ligands were uploaded in patch dock for docking analysis.

Molecular docking: {#s2c}
------------------

The Patchdock server was used to find out the interaction between βcantenine and selected natural alkaloid compounds. PatchDock identified the top first candidate solutions based on shape complementarily of soft molecular surfaces. The clustering RMSD was set to 4.0 Å as proposed by the software developer for bigger molecules and the complex type was set to default. The PatchDock algorithm splits the Connolly dot surface illustration of the molecules into concave, convex and flat patches. Then, complementary patches are coordinated in order to create the candidate transformations of docked complex (the candidate transformations are the docked complexes of specified receptor and ligand molecule based on the patchdock theory). The result was retrieved from the e-mail address given and downloaded \[[@R11],[@R12]\].

Molecular descriptors calculation: {#s2d}
----------------------------------

Smiles notation of compounds was used to calculate the molecular descriptors of selected compounds using Molinspiration (www.molinspiration.com). They molecular descriptors like log P, molecular weight, polar surface area, number of atoms, number of rotatable bond, number of O or N, number of OH or NH, ion channel modulator, drug-likeness and number of violations to Lipinski\'s rule were calculated in the present study \[[@R13]\].

Analysis of ADME of selected compounds: {#s2e}
---------------------------------------

The ADME calculation of selected natural compounds was performed by Lipinski filter (http://www.scfbio-iitd.res.in/software/drugdesign/lipinski.jsp), according to which an orally active drug must obey at least of four of the five laid down criterion for drug likeness namely: molecular mass, cLogP, hydrogen donor and acceptor and molar refractive index \[[@R14]\].

Results and discussion: {#s3}
=======================

We took 10 alkaloid groups of natural compounds for the study. Based on the analysis of docking studies best five were shown in [Table 2](#T2){ref-type="table"}. The atomic contact energy (ACE) value of selected 5-alkaloid compounds range from -191.07 to -131.13 Kcal/. Thus from the calculated ACE values it can be inferred that these compounds showed the favorable binding energy with β-catenin protein. Ligplot analysis shows the hydrogen bonding and the length of their interaction with the key residues of the beta-catenin in the active site pocket. Among the residues which play a vital role in the mechanisms of action we found that the SER 20, ASN 34, LYS 22, LYS 270, SER 351, ARG 469, LYS 345 are the main interacting amino acids residues ([Figure 2](#F2){ref-type="fig"}). With regard to physiochemical properties, all the five alkaloid compounds showed nil violation and complied well with the Lipinski\'s rule of five as shown in [Table 3](#T3){ref-type="table"}. In the same way, [Table 4](#T4){ref-type="table"} shows the ADME profile of the five selected alkaloids; all the ligands are predicted to have high gastrointestinal (GI) absorption effect. Thus the results of PatchDock and ADME analysis clearly showed that selected five alkaloids group of natural compounds have the capacity to inhibit the β-catenin protein.

Conclusions: {#s4}
============

We report the binding properties of phytocompounds like Aristolochicacid, Cryptopleurine, Demecolcine, Fagaronine, Thalicarpine with beta-catenin in the context of colorectal cancer for further consideration and evaluation towards potential treatment.
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###### List of selected alkaloids compounds

  S. No   Compound Name        Source of plant
  ------- -------------------- -----------------------------
  1       Aristolochic acid    Aristolochia indica L.
  2       Camptothecin         Camptotheca acuminata Decne
  3       Colchicine           Colchicum speciosum Steven
  4       Cryptopleurine       Crinum macrantherium Engl
  5       Epipodophyllotoxin   Podophyllum species L.
  6       Demecolcine          Colchicumspeciosum Steven
  7       Fagaronine           Fagara zanthoxyloides Lam
  8       Oxyacanthine         Berberis asiatica Roxb.
  9       Thalicarpine         Thalictrum dasycarpum Fisch

###### Molecular docking results obtained through Patch dock server

  S. No   Compound name      Score   ACE
  ------- ------------------ ------- ----------
  1       Aristolochicacid   3972    -133.63 
  2       Cryptopleurine     4662    -191.07
  3       Demecolcine.       4392    -131.13 
  4       Fagaronine         4278    -133.21 
  5       Thalicarpine       6476    -172.51

###### Calculated molecular Descriptors using Mol inspiration

  Compound name                                                                                                                                                                                                                                                                                                   Mi LogP^a^   TP Sa^b^   N atoms^c^   MW ^d^   N On^e^   N OHNH^f^   N Violat ions^g^   nrotb^h^   volume^i^
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------ ---------- ------------ -------- --------- ----------- ------------------ ---------- -----------
  Aristolochicacid                                                                                                                                                                                                                                                                                                3.57         110.8      25           341.3    8         1           0                  3          271.8
  Cryptopleurine                                                                                                                                                                                                                                                                                                  4.55         30.9       28           377.4    4         0           0                  3          357.4
  Demecolcine                                                                                                                                                                                                                                                                                                     1.74         66         27           371.4    6         1           0                  3          357.4
  Fagaronine                                                                                                                                                                                                                                                                                                      0            51.8       26           350.4    5         1           0                  3          316.3
  ^a^Logarithm of partition coefficient between n-octanol and water (miLogP).^b^Topological polar surface area (TPSA).^c^Number of hydrogen bond acceptors (n-ON). ^d^Number of hydrogen bond donors (n-OHNH).^e^Number of rotatable bonds (n-rotb).^f^Percentage of absorption (%ABS).^g^Molecular weight (MW)                                                                                                     

###### Calculated ADME Properties

  Compound name                                                                                                                                                                                                                 Molecular Mass ^a^   Hydrogen bond donor ^b^   Hydrogen bond donor ^c^   LOGP ^d^   Molar Refractivity ^e^
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------- ------------------------- ------------------------- ---------- ------------------------
  Aristolochicacid                                                                                                                                                                                                              341                  1                         7                         3.336698   87.742668
  Cryptopleurine                                                                                                                                                                                                                377                  0                         4                         4.696699   111.929962
  Demecolcine.                                                                                                                                                                                                                  371                  1                         6                         2.6694     103.425674
  Fagaronine                                                                                                                                                                                                                    350                  1                         4                         3.341899   99.786171
  Thalicarpine                                                                                                                                                                                                                  696                  0                         10                        5.30418    68.041779
  ^a^Molecular mass less than 500 Dalton; ^b^High lipophilicity (expressed as LogP less than 5); ^c^Less than 5 hydrogen bond donors; ^d^Less than 10 hydrogen bond acceptors;^e^Molar refractivity should be between 40-130.                                                                                       
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